Action to Cure Kidney Cancer (ACKC) 

ACKC is the only major kidney cancer grassroots advocacy organization raising funds
that go predominantly to support kidney cancer research.

We don’t accept money from Big Pharma or any other treatment stakeholders.

Advance

RESEARCH FUNDING
Advocate for federal funding of kidney cancer research including DoD’s KCRP and NCI’s SPORE; grant awards to institutions, scientists, and projects

Inform

CANCER COMMUNITY
Share news and knowledge about kidney cancer causes, stages, treatment, prevention; educate policymakers, empower patients and caregivers

Promote

CANCER AWARENESS
Understand causes, expose inequities (racial, ethnic, gender, geographic) and obstacles (uninsured, drug costs); identify stakeholder roles and agendas

Support

ACKC MISSION
Help achieve our purpose; donate; join us to fundraise, lobby elected officials, comment on news and point-of-view posts, engage on social media

Fuel Our Fight

Every 6 minutes someone is diagnosed with kidney cancer, and nearly 14,000 will die this year.* Yet funding for research lags behind other cancers. Learn more

*In the US • Source: American Cancer Society

Campaigns for Federal Research Funding

ACKC’s Capitol Hill advocacy has generated $198 million in Congressional appropriations for kidney cancer research through FY 2022.

Direct Funding to Kidney Cancer Researchers

Since 2006, ACKC has granted more than $465,000 to promising scientists and their institutions.

Independent Research and Analysis

“ACKC Investigates” takes an in-depth look at causes of kidney cancer, exposes inequities and obstacles to care, and delves into stakeholder roles and agendas.

News Highlights

Headline snippets, curated by ACKC, that may be of interest — directly or tangentially — to our kidney cancer community.
Link below for more articles, detailed summaries, and original sources.

President signs omnibus bill including $50M for kidney cancer research…Standard fetus DNA test can diagnose maternal cancer…Cause of death in CT prisons…Tumors eventually develop resistance to immunotherapies by one tumor cell hiding inside another tumor cell…Walking is fine, but “brisk” walking is finer in the search for longevity…5-org meetup about healthcare disparities…

ACKC Blog

Information related to treatment therapies, prevention of disease, maintaining a healthy lifestyle, and overcoming obstacles to effective care, including original research and our own independent analysis.

Therapeutics Updates
Triplet Therapy for Kidney Cancer

Dr. Toni Choueiri, the principal investigator, from Dana Farber Institute, presented the results of the much-anticipated Phase III trial, COSMIC-313, at the 2022 European Society for Medical Oncology (ESMO) Conference in Paris. COSMIC-313 is the first triplet drug...

ACKC News
ACKC Awards $50,000 Research Grant

In August of 2022, Action to Cure Kidney Cancer awarded a $50,000 grant to support the work of the National Cancer Institute’s Urologic Oncology Branch, specifically target toward kidney cancer. In the words of W. Marston Linehan, the Chief of the Branch:...

ACKC Investigates
High Cost of Cancer Drugs

In 2006, Mike from Pennsylvania was diagnosed with advanced kidney cancer that had spread to his ribs.  His doctor prescribed Sutent (sunitinib), at the time, a newly approved Pfizer drug, which cost $179 for a 50 mg pill. The dosage for Sutent is one pill daily...

Kidney Cancer News
Patient Survival and COVID-19 Vaccines

A group of researchers and doctors belonging to the OnCovid Study Group published a retrospective study of survival rate and other factors, in Europe, of vaccinated versus unvaccinated cancer patients. The article was published in the June 2, 2022 issue of Lancet...

ACKC Investigates
Water Contamination in Parkersburg, WV

The chemical site near Parkersburg, WV, source of the waste at the center of the DuPont class-action lawsuit. Source: The New York TimesThis story begins in October 1996 on Wilbur Earl Tennant’s farm outside of Parkersburg, WV, a town of 30,000 people located...

News About Kidney Cancer Therapies

Keep current with best practices regarding kidney cancer care, findings from studies and trials, and recent FDA approvals.

Stay Connected

Join ACKC’s online community of survivors, caregivers, family and friends by liking us on Facebook…we’re 11,000+ members strong.